Ethan Fung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ethan Fung has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Peter J. Taub
Icahn School of Medicine at Mount Sinai
6 shared publicationsJacquelyn M. Roth
Icahn School of Medicine at Mount Sinai
4 shared publicationsBernice Z. Yu
Icahn School of Medicine at Mount Sinai
3 shared publications- Bernice Z. Yu
Division of Plastic and Reconstructive Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3 shared publications - Jacquelyn Roth
Icahn School of Medicine at Mount Sinai
3 shared publications Keisha E. Montalmant
Division of Plastic and Reconstructive Surgery, Icahn School of Medicine at Mount Sinai, New York, USA
3 shared publications
Latest Publications
- 15 October 2025
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 63 (8) , 2578-2586
Impact of Demographics and Comorbidities on Timing of Primary Cleft Lip Repair: Trends Over 10 Years
Objective: Optimal timing for primary cleft lip (CL) repair remains controversial due to a paucity of literature reporting outcomes. This study sought to identify trends in timing of CL repair over a 10-year period. Design and Setting: Cross-sectional analysis of the National Surgical Quality Improvement Program-Pediatrics (NSQIP-P) between 2013 and 2022. Patients, Participants, Interventions: CL patients undergoing primary CL repair were divided into 4 cohorts based on age (months) at repair: 0 to 3, 3 to 6, 6 to 9, and 9 to 12. Main Outcome Measure: Univariable statistics, multivariable regressions, and trend analyses were conducted to identify predictors for operation at latter ages and to evaluate trends over time. Results: 11,585 CL patients were identified with the majority undergoing repair between 3 and 6 months of age (63%). White and Asian patients predominately underwent repair between 0 and 3 months (68% and 5%, respectively), while African American and Hispanic patients underwent repair between 9 and 12 months (12% and 22%, respectively, P < .001). On regression analysis, patients with cardiac risk factors (CRF), asthma, bronchopulmonary dysplasia, developmental delay, CNS abnormalities, and nutritional supplementation ( P < .001) were more likely to be repaired at later time intervals. Over the past decade, Hispanic and Asian patients undergoing CL repair increased between 0 and 3 (β = 0.06) and 3 and 6 (β = 0.05) months of age, respectively. Patients with CRF and airway abnormalities also significantly increased between 0 and 3 months. Conclusion: The present study identified an increase in non-White patients and patients with severe comorbidities undergoing early CL repair over a 10-year period. Healthcare professionals should note these trends when treating their own patient populations.
- 15 October 2025
- Published by SAGE Publications in The Cleft Palate Craniofacial Journal
- Vol. 63 (8) , 2578-2586
Impact of Demographics and Comorbidities on Timing of Primary Cleft Lip Repair: Trends Over 10 Years
Objective: Optimal timing for primary cleft lip (CL) repair remains controversial due to a paucity of literature reporting outcomes. This study sought to identify trends in timing of CL repair over a 10-year period. Design and Setting: Cross-sectional analysis of the National Surgical Quality Improvement Program-Pediatrics (NSQIP-P) between 2013 and 2022. Patients, Participants, Interventions: CL patients undergoing primary CL repair were divided into 4 cohorts based on age (months) at repair: 0 to 3, 3 to 6, 6 to 9, and 9 to 12. Main Outcome Measure: Univariable statistics, multivariable regressions, and trend analyses were conducted to identify predictors for operation at latter ages and to evaluate trends over time. Results: 11,585 CL patients were identified with the majority undergoing repair between 3 and 6 months of age (63%). White and Asian patients predominately underwent repair between 0 and 3 months (68% and 5%, respectively), while African American and Hispanic patients underwent repair between 9 and 12 months (12% and 22%, respectively, P < .001). On regression analysis, patients with cardiac risk factors (CRF), asthma, bronchopulmonary dysplasia, developmental delay, CNS abnormalities, and nutritional supplementation ( P < .001) were more likely to be repaired at later time intervals. Over the past decade, Hispanic and Asian patients undergoing CL repair increased between 0 and 3 (β = 0.06) and 3 and 6 (β = 0.05) months of age, respectively. Patients with CRF and airway abnormalities also significantly increased between 0 and 3 months. Conclusion: The present study identified an increase in non-White patients and patients with severe comorbidities undergoing early CL repair over a 10-year period. Healthcare professionals should note these trends when treating their own patient populations.
- 10 October 2025
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 48 (1) , 1-10
The use of tranexamic acid in gender-affirming mastectomy: a systematic review and meta-analysis
- 10 October 2025
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 48 (1) , 1-10
The use of tranexamic acid in gender-affirming mastectomy: a systematic review and meta-analysis
- 26 June 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (21) , 6055-6065
Utility of Tranexamic Acid in Reduction Mammaplasty: A Systematic Review and Meta-Analysis
Background The use of tranexamic acid (TXA) in reduction mammaplasty is increasing among plastic surgeons. Its efficacy and impact on complications, however, are not yet well understood. This study aims to comprehensively evaluate the impact of TXA on postoperative outcomes in reduction mammoplasty. Methods A systematic review was conducted according to PRISMA guidelines. Five databases were queried to identify studies reporting TXA application in breast surgery. A dual-screener approach was employed to select reduction mammaplasty studies for full-text screening. Primary outcomes assessed were hematoma and seroma; secondary outcomes assessed were surgical site infection (SSI), nipple-areola complex (NAC) necrosis, drain output, drain duration, and thromboembolic events. Data were pooled, and a meta-analysis was performed. Odds ratios (OR) and mean differences were reported via the Mantel-Haenszel and Inverse-Variance methods, respectively. Results Seven studies with a total of 1396 patients were included, with 53.1% of patients (n = 741) receiving TXA. Of those receiving TXA, 100% of patients received TXA intraoperatively, and 62.6% of patients (n = 464) received both topical and intravenous administration. TXA administration significantly reduced postoperative hematoma formation (OR 0.35; 95% CI [0.20–0.63]; P < 0.001), with 2.3% of patients (n = 17) developing hematomas in the TXA group, compared to 7.2% of patients (n = 47) in those who did not receive TXA. No statistically significant differences were found in seroma rates, SSI, NAC necrosis, or drain duration. No thromboembolic events were reported in either group. Conclusion TXA administration during reduction mammaplasty reduced the incidence of postoperative hematoma formation without increasing complications. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 26 June 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (21) , 6055-6065
Utility of Tranexamic Acid in Reduction Mammaplasty: A Systematic Review and Meta-Analysis
Background The use of tranexamic acid (TXA) in reduction mammaplasty is increasing among plastic surgeons. Its efficacy and impact on complications, however, are not yet well understood. This study aims to comprehensively evaluate the impact of TXA on postoperative outcomes in reduction mammoplasty. Methods A systematic review was conducted according to PRISMA guidelines. Five databases were queried to identify studies reporting TXA application in breast surgery. A dual-screener approach was employed to select reduction mammaplasty studies for full-text screening. Primary outcomes assessed were hematoma and seroma; secondary outcomes assessed were surgical site infection (SSI), nipple-areola complex (NAC) necrosis, drain output, drain duration, and thromboembolic events. Data were pooled, and a meta-analysis was performed. Odds ratios (OR) and mean differences were reported via the Mantel-Haenszel and Inverse-Variance methods, respectively. Results Seven studies with a total of 1396 patients were included, with 53.1% of patients (n = 741) receiving TXA. Of those receiving TXA, 100% of patients received TXA intraoperatively, and 62.6% of patients (n = 464) received both topical and intravenous administration. TXA administration significantly reduced postoperative hematoma formation (OR 0.35; 95% CI [0.20–0.63]; P < 0.001), with 2.3% of patients (n = 17) developing hematomas in the TXA group, compared to 7.2% of patients (n = 47) in those who did not receive TXA. No statistically significant differences were found in seroma rates, SSI, NAC necrosis, or drain duration. No thromboembolic events were reported in either group. Conclusion TXA administration during reduction mammaplasty reduced the incidence of postoperative hematoma formation without increasing complications. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 2 June 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 106, 416-425
Older age may predict expedited care for motivated breast reconstruction patients
- 2 June 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 106, 416-425
Older age may predict expedited care for motivated breast reconstruction patients
- 15 May 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 106, 213-220
Social support holds protective value in breast reconstruction
- 15 May 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 106, 213-220
Social support holds protective value in breast reconstruction
- 1 April 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (3) , 253-257
Exploring the Rise in Adolescent Reduction Mammaplasty
Background: As the obesity epidemic continues to grow, symptomatic macromastia at earlier ages has become increasingly common. Objective: The present study aims to explore trends, risk factors, and postoperative complications in adolescent reduction mammaplasty (ARM) over an 11-year period. Methods: The American College of Surgeons National Surgical Quality Improvement Program–Pediatrics (NSQIP-P) was queried to identify ARM cases between 2012–2022 in patients 18 years or younger. Patient demographics, procedure details, and postoperative outcomes were collected. Trend analysis and predictors for postoperative complications were performed via linear regression and multivariable logistic regression, respectively. Results: Between 2012 and 2022, 3158 patients underwent ARM. The overall complication rate was 4.4%, with superficial surgical site infections at 3.0%. Among those who underwent ARM, elevated body mass index (adjusted odds ratio 1.04, P < 0.001) and higher American Society of Anesthesiologists (ASA) class predicted complications (ASA1: adjusted odds ratio 0.34, P = 0.01). The prevalence of ARM increased by 482%, while overall obesity rates increased by 58% over the years. Total operation time (P = 0.005), anesthesia duration (P = 0.02), and length of stay (P < 0.001) decreased throughout the years, while superficial surgical site infections increased (P = 0.04). Conclusion: As obesity rates rise, the prevalence of ARM has increased even more rapidly, with elevated body mass index and higher ASA individuals at an increased risk for complications. Operative time, anesthesia duration, and length of stay decreased over time, with low overall complication rates. Plastic surgeons should note these trends to provide adequate care for patients requesting ARM.
- 1 April 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (3) , 253-257
Exploring the Rise in Adolescent Reduction Mammaplasty
Background: As the obesity epidemic continues to grow, symptomatic macromastia at earlier ages has become increasingly common. Objective: The present study aims to explore trends, risk factors, and postoperative complications in adolescent reduction mammaplasty (ARM) over an 11-year period. Methods: The American College of Surgeons National Surgical Quality Improvement Program–Pediatrics (NSQIP-P) was queried to identify ARM cases between 2012–2022 in patients 18 years or younger. Patient demographics, procedure details, and postoperative outcomes were collected. Trend analysis and predictors for postoperative complications were performed via linear regression and multivariable logistic regression, respectively. Results: Between 2012 and 2022, 3158 patients underwent ARM. The overall complication rate was 4.4%, with superficial surgical site infections at 3.0%. Among those who underwent ARM, elevated body mass index (adjusted odds ratio 1.04, P < 0.001) and higher American Society of Anesthesiologists (ASA) class predicted complications (ASA1: adjusted odds ratio 0.34, P = 0.01). The prevalence of ARM increased by 482%, while overall obesity rates increased by 58% over the years. Total operation time (P = 0.005), anesthesia duration (P = 0.02), and length of stay (P < 0.001) decreased throughout the years, while superficial surgical site infections increased (P = 0.04). Conclusion: As obesity rates rise, the prevalence of ARM has increased even more rapidly, with elevated body mass index and higher ASA individuals at an increased risk for complications. Operative time, anesthesia duration, and length of stay decreased over time, with low overall complication rates. Plastic surgeons should note these trends to provide adequate care for patients requesting ARM.
- 27 March 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (8) , 2773-2777
Trends in Open Versus Minimally Invasive Craniosynostosis Repair: A 10-Year National Analysis
Objective: Techniques for cranial vault reconstruction for craniosynostosis have increasingly shifted towards minimally invasive methods. The present study sought to identify trends in surgical approaches based on demographics and surgical outcomes over the past decade. Methods: The National Surgical Quality Improvement Program-Pediatrics was queried to identify patients with craniosynostosis who underwent cranial vault repair between January 2013 to December 2022. Patient demographics, surgical characteristics, and postoperative outcomes were gathered for both open surgery (OS) and minimally invasive surgery (MIS) groups per year. Trend analysis was performed by linear regression and predictors for MIS were identified using univariable statistics and multivariable logistic regressions. Results: Among 12,104 patients identified, OS rates decreased from 96% to 91%, while the use of MIS increased from 3% to 9% ( P P P P <0.001). Conclusion: The prevalence of MIS for craniosynostosis repair increased over a 10-year period. MIS patients benefit from reduced complication rates, operative time, anesthesia duration, and length of stay. As MIS becomes a more common treatment modality for craniosynostosis, access has expanded to include more complex and diverse patients, though opportunities for improvement still remain.
- 27 March 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (8) , 2773-2777
Trends in Open Versus Minimally Invasive Craniosynostosis Repair: A 10-Year National Analysis
Objective: Techniques for cranial vault reconstruction for craniosynostosis have increasingly shifted towards minimally invasive methods. The present study sought to identify trends in surgical approaches based on demographics and surgical outcomes over the past decade. Methods: The National Surgical Quality Improvement Program-Pediatrics was queried to identify patients with craniosynostosis who underwent cranial vault repair between January 2013 to December 2022. Patient demographics, surgical characteristics, and postoperative outcomes were gathered for both open surgery (OS) and minimally invasive surgery (MIS) groups per year. Trend analysis was performed by linear regression and predictors for MIS were identified using univariable statistics and multivariable logistic regressions. Results: Among 12,104 patients identified, OS rates decreased from 96% to 91%, while the use of MIS increased from 3% to 9% ( P P P P <0.001). Conclusion: The prevalence of MIS for craniosynostosis repair increased over a 10-year period. MIS patients benefit from reduced complication rates, operative time, anesthesia duration, and length of stay. As MIS becomes a more common treatment modality for craniosynostosis, access has expanded to include more complex and diverse patients, though opportunities for improvement still remain.
- 12 March 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 104, 259-272
The current state of tranexamic acid in mastectomy and breast reconstruction: A systematic review and meta-analysis
- 12 March 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 104, 259-272
The current state of tranexamic acid in mastectomy and breast reconstruction: A systematic review and meta-analysis
- 2 December 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (5) , 2170-2176
Intraoral Microscopic Versus Robot‐Assisted Sialolithotomy and Sialendoscopy for Submandibular Stones
Objective: Sialendoscopy has remained the standard of treatment for sialolithiasis; however, large stones impacted in the submandibular gland hilum often require an intra‐oral combined approach.Methods: Patients treated for submandibular hilar sialolithiasis from 2015 to 2021 at two tertiary centers were stratified into two groups based on the surgical technique: Intraoral Microscopic‐Assisted Sialolithotomy (IMAS) versus Robot‐Assisted Sialolithotomy and Sialendoscopy (RASS). We compared the characteristics of retrieved stones, surgical success rate, operative time, and post‐operative complications in both techniques. True surgical success was defined as successful stone extraction without reoccurrence within 12 months.Results: The RASS technique was attempted in 60 patients and successful in 56 (93.3%) cases whereas the IMAS technique was performed in 52 patients and successful in 48 (92.3%) cases. The longest dimension of the predominant retrieved calculi was 9.6 ± 3.1 mm (range, 5–18 mm) for the robotic technique and 10 ± 4.8 mm (range, 5–30 mm) for the microscopic technique. The operative time for the robotic technique excluding robot setup time was 70.6 ± 24.8 min compared to 61.9 ± 42.4 min for microscopic technique (p = 0.018). No major adverse outcomes were reported; however, temporary lingual paresthesia was found in ten robotic (16.7%) and five microscopic (9.6%) cases.Conclusion: The two techniques were comparable in terms of efficacy and safety for large stones. The robot has the advantage of intraoral high dynamic maneuverability and improved surgeon posture while the microscopic technique has the advantage of intraoral tactile feedback. The procedure was significantly shorter in duration with the microscope.Level of Evidence: 3 Laryngoscope, 134:2170–2176, 2024
- 2 December 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (5) , 2170-2176
Intraoral Microscopic Versus Robot‐Assisted Sialolithotomy and Sialendoscopy for Submandibular Stones
Objective: Sialendoscopy has remained the standard of treatment for sialolithiasis; however, large stones impacted in the submandibular gland hilum often require an intra‐oral combined approach.Methods: Patients treated for submandibular hilar sialolithiasis from 2015 to 2021 at two tertiary centers were stratified into two groups based on the surgical technique: Intraoral Microscopic‐Assisted Sialolithotomy (IMAS) versus Robot‐Assisted Sialolithotomy and Sialendoscopy (RASS). We compared the characteristics of retrieved stones, surgical success rate, operative time, and post‐operative complications in both techniques. True surgical success was defined as successful stone extraction without reoccurrence within 12 months.Results: The RASS technique was attempted in 60 patients and successful in 56 (93.3%) cases whereas the IMAS technique was performed in 52 patients and successful in 48 (92.3%) cases. The longest dimension of the predominant retrieved calculi was 9.6 ± 3.1 mm (range, 5–18 mm) for the robotic technique and 10 ± 4.8 mm (range, 5–30 mm) for the microscopic technique. The operative time for the robotic technique excluding robot setup time was 70.6 ± 24.8 min compared to 61.9 ± 42.4 min for microscopic technique (p = 0.018). No major adverse outcomes were reported; however, temporary lingual paresthesia was found in ten robotic (16.7%) and five microscopic (9.6%) cases.Conclusion: The two techniques were comparable in terms of efficacy and safety for large stones. The robot has the advantage of intraoral high dynamic maneuverability and improved surgeon posture while the microscopic technique has the advantage of intraoral tactile feedback. The procedure was significantly shorter in duration with the microscope.Level of Evidence: 3 Laryngoscope, 134:2170–2176, 2024